These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 31111216

  • 21. Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation.
    Shaked A, Ghobrial RM, Merion RM, Shearon TH, Emond JC, Fair JH, Fisher RA, Kulik LM, Pruett TL, Terrault NA, A2ALL Study Group.
    Am J Transplant; 2009 Feb; 9(2):301-8. PubMed ID: 19120082
    [Abstract] [Full Text] [Related]

  • 22. Living-donor liver transplantation for congenital biliary atresia with porto-pulmonary hypertension and moderate or severe pulmonary arterial hypertension: Kyoto University experience.
    Ogawa E, Hori T, Doi H, Segawa H, Uemoto S.
    Clin Transplant; 2014 Sep; 28(9):1031-40. PubMed ID: 24986560
    [Abstract] [Full Text] [Related]

  • 23. [Postoperative intensive care of biliary atresia patients treated with living donor liver transplantation].
    Deng YH, Guo CB, Zhang MM, Li YC.
    Zhonghua Er Ke Za Zhi; 2011 Jan; 49(1):21-6. PubMed ID: 21429307
    [Abstract] [Full Text] [Related]

  • 24. Impact of Monosegment Graft Use for Infants in Pediatric Living Donor Liver Transplantation.
    Ueno T, Toyama C, Deguchi K, Masahata K, Nomura M, Watanabe M, Kamiyama M, Tazuke Y, Bessho K, Okuyama H.
    Transplant Proc; 2022 Mar; 54(2):391-394. PubMed ID: 35074162
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effectiveness of Perioperative Immunologic Markers Monitoring for Predicting Early Acute Cellular Rejection After Living Donor Liver Transplantation.
    Han ES, Na GH, Choi HJ, You YK, Kim DG.
    Transplant Proc; 2019 Oct; 51(8):2648-2654. PubMed ID: 31477418
    [Abstract] [Full Text] [Related]

  • 28. Impact of donor-recipient genetic relationship on outcome of living donor liver transplantation.
    Ali MA, Elshobari MM, Salah T, Kandeel AR, Sultan AM, Elghawalby AN, Shehta A, Elsayed U, Fathy O, Yassen A, Wahab MA.
    Liver Transpl; 2017 Jan; 23(1):43-49. PubMed ID: 27516392
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antibody-mediated rejection in pediatric liver transplant recipients.
    Markiewicz-Kijewska M, Kaliciński P, Kluge P, Piątosa B, Rękawek A, Jankowska I, Kostecka E, Kurowski PN.
    Ann Transplant; 2014 Mar 04; 19():119-23. PubMed ID: 24594760
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effects of recipient size and allograft type on pediatric liver transplantation for biliary atresia.
    Alexopoulos SP, Nekrasov V, Cao S, Groshen S, Kaur N, Genyk YS, Matsuoka L.
    Liver Transpl; 2017 Feb 04; 23(2):221-233. PubMed ID: 27862929
    [Abstract] [Full Text] [Related]

  • 33. The risk factors of fungal infection in living-donor liver transplantations.
    Ohkubo T, Sugawara Y, Takayama T, Kokudo N, Makuuchi M.
    J Hepatobiliary Pancreat Sci; 2012 Jul 04; 19(4):382-8. PubMed ID: 21792556
    [Abstract] [Full Text] [Related]

  • 34. Revisiting chronic rejection following living donor liver transplantation in the tacrolimus era: A single center experience.
    Choudhary NS, Saraf N, Saigal S, Gautam D, Rastogi A, Goja S, Bhangui P, Srinivasan T, Yadav SK, Soin A.
    Clin Transplant; 2018 Feb 04; 32(2):. PubMed ID: 29160909
    [Abstract] [Full Text] [Related]

  • 35. Transition of Spleen Volume Long After Pediatric Living Donor Liver Transplantation for Biliary Atresia.
    Kawano Y, Sanada Y, Urahashi T, Ihara Y, Okada N, Yamada N, Hirata Y, Katano T, Taniai N, Matsuda A, Miyashita M, Yoshida H, Mizuta K.
    Transplant Proc; 2018 Nov 04; 50(9):2718-2722. PubMed ID: 30401384
    [Abstract] [Full Text] [Related]

  • 36. Outcome of living donor liver transplantation for post-Kasai biliary atresia in adults.
    Kyoden Y, Tamura S, Sugawara Y, Yamashiki N, Matsui Y, Togashi J, Kaneko J, Kokudo N, Makuuchi M.
    Liver Transpl; 2008 Feb 04; 14(2):186-92. PubMed ID: 18236393
    [Abstract] [Full Text] [Related]

  • 37. Postoperative flow cytometry crossmatch in living donor liver transplantation: clinical significance of humoral immunity in acute rejection.
    Kasahara M, Kiuchi T, Takakura K, Uryuhara K, Egawa H, Asonuma K, Uemoto S, Inomata Y, Ohwada S, Morishita Y, Tanaka K.
    Transplantation; 1999 Feb 27; 67(4):568-75. PubMed ID: 10071029
    [Abstract] [Full Text] [Related]

  • 38. Liver transplantation for biliary atresia: A single-center study from mainland China.
    Li QG, Wan P, Zhang JJ, Chen QM, Chen XS, Han LZ, Xia Q.
    World J Gastroenterol; 2015 Aug 28; 21(32):9638-47. PubMed ID: 26327772
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Plugged percutaneous biopsy of the liver in living-donor liver transplantation recipients suspected to have graft rejection.
    Kim SJ, Won JH, Kim YB, Wang HJ, Kim BW, Kim H, Kim J.
    Acta Radiol; 2017 Jul 28; 58(7):771-777. PubMed ID: 27754919
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.